Accessibility Menu

Accessibility Statemnet

http://cannassure.life מחויב לספק באתר תוכן נגיש לקהל הרחב ככל שניתן, ללא כל קשר לטכנולוגיה בה נבנה האתר. אנחנו פועלים לעדכן ולהטמיע את כללי הנגישות ככל שניתן בהתאם לעקרונות תקן הנגישות. האתר עומד בהתאם לדרישות הנגישות לרמה 2 (AA) של ארגון W3C . בקישורים תמצאו פירוט התנאים בהם עומד האתרבעברית ובאנגלית. בנוסף האתר נבנה לפי התקן של W3C ל- CSS ו- HTML האתר מותאם לתצוגה בדפדפנים המובילים.

מבנה האתר והתאמות נגישות

תכני האתר כתובים באופן מסודר והיררכי. במידת הצורך קיימים הסברים לצד התוכן.

לכל התמונות באתר יש הסבר טקסטואלי חלופי (alt).

איזורי הפוקוס מסומנים באופן ברור.

חוקי ARIA

באתר זה הוטמעו חוקי ARIA העוזרים לפרש את תוכן האתר בצורה מדויקת וטובה יותר, עבור קןראי מסך, והוטמעו הודעות והתראות יחודיות לפריטים אנטראקטיבים שונים (פופ-אפים טפסים וכו’)

תפריט נגישות

באתר קיים תפריט נגישות ייעודי. ניתן לפתוח אותו בלחיצה על האייקון . דרך התפריט ניתן לעצור אנימציות, להגדיל קונטרסט, להדגיש קישורים ולשנות את גודל הפונט.

נתקלתם בבעיה? ספרו לנו!

באתר זה הושקעו מאמצים רבים על מנת להפוך אותו לנגיש ושימושי עבור כלל הגולשים. אנחנו משתדלים לשמור ולתחזק את האתר ברמה הטובה ביותר. במידה ומצאתם ו/או נתקלתם בקשיים בגלישה באתר, אל תהססו לדווח לנו לכתובת המייל: ran.amir@cannassure.life.

אנחנו נטפל בבעיה ונחזור אליכם בהקדם עם פרטים על טיפולה.

תאריך עדכון אחרון של ההצהרה: 20/06/19

We do it right.

Our Story

In 2016, Cannassure co-founder and entrepreneur Nir Peles set out on a challenge, to raise the standards of medical cannabis in the global market.

A close friend had been living with chronic pain for years. After treating with CBD, he experienced great relief but was unable to experience consistent alleviation of pain, due to the instability of products in the market. Nir and business partner Shimon Bar-Kama owned a successful botanical extraction and manufacturing company and saw an opportunity to apply their know-how and experience of precision extracting to medical cannabis.

Their vision was to become a leading, world-class, trusted developer and provider of top-quality-grade medical cannabis products. They wanted to ensure consistent, uniform and stable medical cannabis products that would be reliable and effective for different therapeutic treatments. They aspired to make medical cannabis products at a pharmaceutical level, in formulated and precise dosages. They embarked on building a state-of the-art medical cannabis operation that would embody all the stages of product creation, from seed to package, to ensure a quality second-to-none.



Leadership

  • Major General Ido Nehushtan

    Major General Ido Nehushtan

    Chairman of the Board

    Former commander of the Israel Air Force and Head of the IDF Planning Directorate, Mr. Nechushtan brings extensive managerial experience, including formulating strategy, creating work plans and leading processes. These he performed in the Air Force, the IDF and the private sector, in the fields of technology and cyber. He holds a B.Sc. cum laude in Mathematics and Computer Science from the Hebrew University of Jerusalem, an MBA from Northwestern University and Tel Aviv University, and an Advanced Management Program (AMP) from Harvard University.

  • Nir Peles, CPA, MBA, MA(LAW)

    Nir Peles, CPA, MBA, MA(LAW)

    Founder, BOD Member & VP Business Development

    A seasoned entrepreneur with extensive knowledge in business development and company transformation. A former executive at Bluephoenix Solutions (NASDAQ: MDSY) and Alcobra Pharma (NASDAQ: ADHD), Mr. Peles holds a BA in Economics and Accountancy from the Hebrew University of Jerusalem and an MBA and MA (Law) degree from Tel Aviv and Bar Ilan Universities.

  • Ran Amir

    Ran Amir

    CEO and BOD Member

    Having over 15 years of extensive international experience in operations management and management consulting, Mr. Amir has served 8 years in an executive position at The Bread Factory, a top of the range UK based food manufacturer, and 5 years as Solbar’s CEO. Mr. Amir holds a B.Sc in Industrial Engineering and Management and M.Sc in International Business from Birkbeck, University of London.

  • Dr. Hadile Ounallah-Saad

    Dr. Hadile Ounallah-Saad

    VP R&D

    Bringing extensive experience in drug delivery systems and drug device combination; holding a Ph.D in Medical Science (neurobiology) from the Hadassah Medical School and a postdoctoral training in neurobiology from Haifa University, where she was appointed for a postdoctoral fellowship, Eshkol Laurate, 2012 – 2014 on novel approaches for Alzheimer Disease therapy. Her field of expertise is neurodegenerative disorders.

  • Dana Marom

    Dana Marom

    Chief Quality Manager

    With 15 years of extensive, international experience in Quality Management and R&D, Dana has previously served in senior management positions in companies such as GreenMarket, China and provided consulting services for the food manufacturing sector. Mrs. Marom holds a B.Sc in Biochemistry and Food Technology from the Hebrew University of Jerusalem and an EMBA from the College of Management Academic Studies.

  • Steven Eitan

    Steven Eitan

    VP Strategy

    Bringing 30 years of experience in leading and managing international biomed and hi-tech companies from start-up to market penetration and sales, including business and clinical strategy, raising finance, technological development, establishing marketing and sales systems. Over the years, Steven has managed publicly traded companies including Exalenz Bioscience (TASE: EXEN) and Micromedic Technologies (TASE: MCTC).

  • Adi Neufeld

    Adi Neufeld

    CFO

    With 13 years of experience in various finance positions, Mr. Neufeld has served three years as the CFO of Solbar Food Technologies. Previously, Mr. Neufeld held positions at CHS Inc (NASDAQ: CHSCP). U.S. headquarters working for their Processing and Food Ingredients Division and at PWC Israel. Mr. Neufeld earned his Bachelor's Degree in Accounting and Economics from the Ben-Gurion University of the Negev.

  • Dr. Hadar Less

    Dr. Hadar Less

    Agri-Consultant

    Dr. Less is a multi-disciplinary, R&D professional with unique expertise in Life Sciences, Genetics, and Bioinformatics. He has over a decade of experience leading R&D and operational business units for several international companies, including Syngenta (NASDAQ: SYENF) and Compugen (NASDAQ: CGEN). Dr. Less holds a Ph.D from the Weizmann Institute of Sciences, Department of Plant Science; an M.Sc in physiology and immunology from the Israel Institute of Technology’s Faculty of Medicine; and a B.Sc in Animal Science from the Hebrew University of Jerusalem, Faculty of Agriculture.

  • Mr. Shimon Barkama

    Mr. Shimon Barkama

    BOD member

    An experienced CEO, Director, and Partner of several companies spanning a number of industries, Mr. Bar Kama is proficient in corporate strategy, manufacturing and global expansion. He holds an Aeronautical Engineering degree from the Technion in Haifa, IL. Additionally, Bar-Kama served as an Israeli Air Force Fighter Pilot, both in regular and reserve service, for 32 years.

  • Hadar Cohen

    Hadar Cohen

    Production Manager

    With 20 years of manufacturing experience in the pharmaceutical industry, Mr. Cohen has served as the Production Manager at Kamada Ltd. (TASE: KMDA, NASDAQ: KMDA). Well versed in FDA regulatory processes, cGMP requirements and manufacturing processes in a cleanroom environment, Mr. Cohen brings extensive knowledge of drug developmental processes and sterile operations. He has a Bachelor's degree in Bio-Tech Enginerering and Industrial Management from Sapir College.

  • Alon Bilu

    Alon Bilu

    Senior Agronomist

    Bringing over 25 years experience in agriculture and agritech management, Mr. Alon Bilu is an experienced Agronomist with vast skills in plant breeding and cultivation. He is an expert in planning and outfitting agricultural systems for plant based food and seed production. During his extensive career, he led the Growth Department at Evogene (Nasdaq: EVGN) and the new seed production department at Syngenta, leading biotech companies. Mr. Bilu holds a degree in Agriculture, Food and Environmental Quality B.Sc.Agri and M.Sc.Agri from the Hebrew University of Jerusalem, Faculty of Rehovot.

  • Ada Kaster

    Ada Kaster

    Analytical Chemist

    With over 2 decades of experience in R&D and QC in medical laboratories, Ms. Kaster is a Senior Analytical Chemist with specialization in pharmaceutical testing methods, performance and validation. She is proficient in many analytical techniques and in the operation of cutting edge equipment. Ms. Kaster has worked in the pharmaceutical industry in companies like Teva (TEVA: NYSE) (TEVA: TASE) and Foamix (NASDAQ: FOMX). She has a B.Ch.E. from the College of Acedemic Engineering, Sami Shimon, and a degree in Biotechnological Engineering from the Ort College, Carmiel.

  • Dr. Itay Levy

    Dr. Itay Levy

    Product Development Coordinator 

    Bringing advanced knowledge of medicinal chemistry and nano-technology, Dr. Itay Levy is a valued member of Cannassure's Product Development Team. An expert in bio-active materials and applications, Dr. Levy specialized in cannabis research for biomedical applications at the Volcani Center, Israel's leading agricultural research organization. Dr. Levy is a PH.D. graduate of Bar Ilan University.

  • Trevor Meredith

    Trevor Meredith

    Development Engineer

    Bringing over 40 years of experience in the fields of extraction, evaporation and drying techniques, Mr. Meredith has served throughout his career as QA Manager, R&D Manager, Chief Technologist and Senior Process Engineer, while supporting raw material purchasing programs, international production operations and auditing international suppliers. Mr. Meredith holds a Diploma in Sugar Chemistry manufacturing from the Queensland Institute of Technology and studied at The Sugar Research Institute of Australia.

  • Bar Izardel

    Bar Izardel

    Extraction Specialist

    Bringing over 10 years of hands on experience of medical cannabis extraction, Mr. Bar Izardel specializes in different methods and procedures of extracting crude oil and isolating singular cannabinoids.

  • Ilana Shukrun

    Ilana Shukrun

    Book Keeper

  • Nissim Balas

    Nissim Balas

    Process Development & Quality Assurance Manager

    Bringing extensive experience in the Biopharmaceutical/Biotechnology/Biochemistry industry, in the field of Chemistry Manufacturing and Control (CMC) in Down Stream Process (DSP) development and in Quality Assurance management. Including: * Protein purification process for biological/biopharmaceutical products (involving formulation development and analytical methods for proteins). * Research and development in biology/Biochemistry. * Quality Assurance management. Including: Documentation control, Scientific review and approval of Development Reports, Approval of Validation Protocols and Reports, Participated in internal/external audits, etc.

  • Ayelet Levav

    Ayelet Levav

    HR Generalist

Executive Team

  • Major General Ido Nehushtan

    Major General Ido Nehushtan

    Chairman of the Board

  • Nir Peles, CPA, MBA, MA(LAW)

    Nir Peles, CPA, MBA, MA(LAW)

    Founder, BOD Member & VP Business Development

  • Ran Amir

    Ran Amir

    CEO and BOD Member

  • Dr. Hadile Ounallah-Saad

    Dr. Hadile Ounallah-Saad

    VP R&D

  • Dana Marom

    Dana Marom

    Chief Quality Manager

  • Steven Eitan

    Steven Eitan

    VP Strategy

  • Adi Neufeld

    Adi Neufeld

    CFO

  • Dr. Hadar Less

    Dr. Hadar Less

    Agri-Consultant

  • Mr. Shimon Barkama

    Mr. Shimon Barkama

    BOD member

Team

  • Hadar Cohen

    Hadar Cohen

    Production Manager

  • Alon Bilu

    Alon Bilu

    Senior Agronomist

  • Ada Kaster

    Ada Kaster

    Analytical Chemist

  • Dr. Itay Levy

    Dr. Itay Levy

    Product Development Coordinator 

  • Trevor Meredith

    Trevor Meredith

    Development Engineer

  • Bar Izardel

    Bar Izardel

    Extraction Specialist

  • Ilana Shukrun

    Ilana Shukrun

    Book Keeper

  • Nissim Balas

    Nissim Balas

    Process Development & Quality Assurance Manager

  • Ayelet Levav

    Ayelet Levav

    HR Generalist

Our Partners

  • Solbar Food Technologies

    Solbar Food Technologies

    Cannassure was founded by Solbar Food Technlogies, a leading food manufacturer, with 60 years of applied industrial expertise and know-how. Solbar extracts and processes botanicals, in large industrial scale, operating in accordance with top-quality standards. The Solbar Group provides Cannassure with skillful mastery accumulated over decades of successful operation, having served customers over the years that included leading, global food and pharmaceutical companies. They have provided Cannassure with facilities, labs, skilled personnel and investment funds. They remain Cannassure's major stakeholder.

  • Hadassah Medical Ltd.

    Hadassah Medical Ltd.

    Cannassure has signed a mutual agreement with Hadassah Medical to market and sell medical cannabis oil worldwide under the Hadassah Medical brand name and to collaborate with Cannassure in their pharmaceutical R&D program of cannabinoid based medicine. Hadassah Medical, is a wholly owned subsidiary of the Hadassah Medical Organization, and leads Hadassah's business development ambitions. The company is part of Hadassah's medical centers in Israel and abroad, which include two university hospitals in Jerusalem as well as schools of medicine, dentistry, nursing, and pharmacology affiliated with the Hebrew University of Jerusalem.

  • Israel Innovation Authority

    Israel Innovation Authority

    The IIA has recognized Cannassure's activity as innovative and has granted us financial support for the application and modification of our botanical extraction methods to medical cannabis.

Interested in next generation medical cannabis opportunities? Become our partner

Partner With Us

Our Vision

Cannassure's vision is to become a leading, world-class, trusted developer and provider of top-quality medical grade cannabis products as well as pharmaceutical cannabinoid medicines, addressing a broad range of unmet medical needs.

Our Mission

Cannassure is developing and commercializing a wide range of effective, high standard and affordable medical cannabis products as well as pharmaceutical cannabinoid medicines, to enhance treatment and improve people's quality of life worldwide. We ensure the highest standards by facilitating a holistic integrated production system including an advanced indoor-aeroponic grow facility that is controlled and pristine, a state-of-the-art extraction and processing facility, together with scientifically advanced R&D. Cannassure is committed to quality, excellence, innovation, and integrity.

Responsibility

Commitment to Quality

Cannassure is committed to developing and producing medical cannabis products of the highest quality. We cultivate our cannabis according to IMC-GAP standards. We grow indoors in a controlled and clean environment to yield the highest quality, pure and consistent cannabis for use in our products. Our high-quality cannabis product range is processed in accordance with IMC-GMP standards, with quality assurance protocols, testing both our unprocessed cultivated cannabis and our manufactured products at different stages of production to ensure pure, effective, stable and consistent products for the duration of their entire shelf life.

Contact Us

* Required Fields

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.